NOD2/CARD15 genotype and common gastrointestinal diseases in 43 600 individuals

Journal of Internal Medicine

Volumn 267, Issue 2, 2010, Pages 228-236

  Yazdanyar, S ^a   Nordestgaard, B G ^a,b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Gastrointestinal disease; General population; Genetic susceptibility; NOD2 CARD15; Polymorphism

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ADULT; AGED; ANUS FISSURE; ANUS FISTULA; APPENDICITIS; ARTICLE; CARD15 GENE; COLORECTAL CANCER; CROHN DISEASE; DIGESTIVE SYSTEM CANCER; DNA POLYMORPHISM; DUODENUM ULCER; DYSPEPSIA; ESOPHAGITIS; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL INFECTION; GENE; GENOTYPE; HUMAN; INNATE IMMUNITY; IRRITABLE COLON; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; NOD2 GENE; PANCREAS CANCER; PERIANAL ABSCESS; PRIORITY JOURNAL; RISK FACTOR; STOMACH ULCER;

ADULT; AGED; AGED, 80 AND OVER; CROHN DISEASE; DENMARK; FEMALE; GASTROINTESTINAL DISEASES; GENOTYPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 74849108904     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02137.x     Document Type: Article

References (25)

1. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001 411 : 599 603.
2. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001 411 : 603 606.
3. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 2004 99 : 2393 2404.
4. Girardin SE, Boneca IG, Viala J et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003 278 : 8869 8872.
5. Frikke-Schmidt R, Nordestgaard BG, Stene MC et al. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA 2008 299 : 2524 2532.
6. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007 298 : 299 308.
7. Schnohr P, Jensen JS, Scharling H, Nordestgaard BG. Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12 000 men and women from The Copenhagen City Heart Study. Eur Heart J 2002 23 : 620 626.
8. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008 359 : 1897 1908.
9. van der Net JB, Janssens AC, Eijkemans MJ, Kastelein JJ, Sijbrands EJ, Steyerberg EW. Cox proportional hazards models have more statistical power than logistic regression models in cross-sectional genetic association studies. Eur J Hum Genet 2008 16 : 1111 1116.
10. Alhopuro P, Ahvenainen T, Mecklin JP et al. NOD2 3020insC alone is not sufficient for colorectal cancer predisposition. Cancer Res 2004 64 : 7245 7247.
11. Papaconstantinou I, Theodoropoulos G, Gazouli M et al. Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer 2005 114 : 433 435.
12. Roberts RL, Gearry RB, Allington MD, Morrin HR, Robinson BA, Frizelle FA. Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer. Cancer Res 2006 66 : 2532 2535.
13. Suchy J, Klujszo-Grabowska E, Kladny J et al. Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. BMC Cancer 2008 8 : 112.
14. Szeliga J, Sondka Z, Jackowski M, Jarkiewicz-Tretyn J, Tretyn A, Malenczyk M. NOD2/CARD15 polymorphism in patients with rectal cancer. Med Sci Monit 2008 14 : CR480 4.
15. Tuupanen S, Alhopuro P, Mecklin JP, Jarvinen H, Aaltonen LA. No evidence for association of NOD2 R702W and G908R with colorectal cancer. Int J Cancer 2007 121 : 76 9.
16. Kurzawski G, Suchy J, Kladny J et al. The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res 2004 64 : 1604 1606. (Pubitemid 38428679)
17. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001 357 : 539 545.
18. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002 420 : 860 867.
19. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003 18 (Suppl 2 1 5.
20. Rhodes JM, Campbell BJ. Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med 2002 8 : 10 6.
21. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD. The codependence of angiogenesis and chronic inflammation. FASEB J 1997 11 : 457 465.
22. Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 2000 60 : 184 190.
23. Nakajima N, Kuwayama H, Ito Y, Iwasaki A, Arakawa Y. Helicobacter pylori, neutrophils, interleukins, and gastric epithelial proliferation. J Clin Gastroenterol 1997 25 (Suppl 1 S198 202.
24. Allin KH, Bojesen SE, Nordestgaard BG. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 2009 27 : 2217 2224.
25. Loftus Jr. EV. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004 126 : 1504 1517.